Christopher Posner insider trades
Open-market stock purchases and sales by Christopher Posner, PRESIDENT AND CEO at Cara Therapeutics, Inc, from SEC Form 4 filings since Aug 2, 2018.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- CARA Cara Therapeutics, Inc: 17 sales, last Feb 28, 2025